CBD is proving to be a very valuable medicine, with its therapeutic effects being utilized in the treatment of a wide range of conditions including psychiatric disorders, neuropathic pain, and inflammatory diseases.
However, while research on the health benefits of CBD piles up, do we know if it is safe? According to a recent study from Germany, the answer is yes. With a focus on clinical studies and CBD’s potential to interact with other drugs, researchers from the nova-Institute undertook a review of the available research, in order to assess the safety of cannabidiol.
Although THC has garnered much of the attention surrounding the therapeutic uses of cannabis, in recent years, it’s CBD that has found itself in the spotlight due to its lack of psychoactivity and numerous beneficial pharmacological effects. CBD has now been shown to have anxiolytic, anti-inflammatory, antiemetic, antipsychotic, and neuroprotective properties.
The review even goes so far as to say that, based on current research, CBD is a potentially beneficial treatment for heroin addiction, seizures, psychosis, cancer, and anxiety. Studies also indicate that CBD has no adverse physiological effect on blood pressure, heart rate, body temperature. Moreover, psychological and psychomotor functions are not adversely affected.
Chronic use and high doses of CBD have repeatedly shown to be well tolerated by humans, with no neurological, psychiatric, or clinical adverse effects.
So, while the study does confirm the previously held belief that CBD is safe, even in high doses, and that it offers a plethora of medicinal value, there are still gaps in our knowledge that need to be addressed in order for CBD to realize its potential.